The governance

Board of directors

The IHU is steered by a board of directors (CA) which defines its general policy.
It is made up of 16 members, 6 founding members, 5 qualified personalities, 3 representatives from the economic world and 2 representatives elected by teacher-researchers. The CA is chaired by Mr. Thierry Tuot, State Councillor.

Thierry Tuot

Chairman of the board

“Like all start-ups, ICAN has been able to cast doubt on the viability of its future. The retrospective view that this report now allows us to cast on its growth shows that the future of our IHU is now firmly assured and that its project is being deployed vigorously. These last two years have been those of normalization, of a management that has become rigorous, transparent and efficient; consolidation, by refocusing the institute’s project on its fundamentals; investment, through the acquisition of the unique research MRI which is the key asset of our action; of integration, ICAN having alongside its founders, in close collaboration at all times with them, found its way, its specificity, and the path to its added value. Despite the health crisis (to the resolution of which it contributes for the future) the IHU has remained mobilized, active; he demonstrated that his project was valid and found, in France, in Europe, reliable partners, with whom he writes, as a recognized major player, an essential page of medical research. It owes its success to the unwavering support, which is not a gamble, but a rational choice for the future, of its founding members, Sorbonne University, AP-HP and INSERM. It owes its success first and foremost to its teams, ardent, united, mobilized, professional and imaginative, whose creativity and rigor make the power of the tool they have built. Alongside them, the Board of Directors will continue to support and promote an action whose value will be demonstrated even more in the years to come. »

Representatives of the founders


Managing Director AP-HP

Gilles Bloch

Chairman and CEO INSERM


President Sorbonne University


AP - HP Clinical Research and Innovation Department / Acting Deputy Director AP- HP


Director of the Department of Partnerships and External Relations INSERM

Bruno RIOU

Dean of the Faculty of Medicine

Qualified personalities

Catherine Boileau


Claudine CANALE

President of “Les Poids Plume France”

Jessica LEGUES

CEO MEDICEN, Paris Region


Research Director, INRIA

Representatives of the economic world


GE Healthcare, General Manager, FBFA zone, Representative of SNITEM


SEBIA, Chief Scientist

Representatives of researchers, teacher-researchers

Corinne FRERE

MCU-PH, Biological Hematology, AP-HP

Bruno FEVE


The executive committee

The Executive Committee (COMEX) of the IHU is made up of the Director General, the Secretary General, the heads of the IHU’s internal poles and one community representative per strategic axis. The director of the Pitié-Salpêtrière Hospital Group and the medical director of the DMU are permanent guests. The COMEX is responsible for assisting the Director General, particularly in defining the IHU’s strategy and scientific orientations, but also in all aspects of management.

The Chief Executive Officer is appointed for 4 years by the Chairman of the Board of Directors, from among the candidates proposed by the Board. The Director General is responsible for the general management of the IHU. He is assisted by a Secretary General in charge of the operational management of the Institute.

Prof. Fabrizio ANDREELLI

Endocrinology and metabolism


Endocrinology and metabolism


Endocrinology, Metabolism and Prevention of Cardiovascular Diseases

Prof. Alain Combès

Intensive medicine-resuscitation


Cardiology and vascular diseases

Prof. Richard ISNARD

Cardiology and vascular diseases

Mathilde LEFEVRE

Director of Research APHP.6 (GH)

Philippe LESNIK

Biology of atherosclerosis

Prof. Irene NETCHINE

Physiology - Pediatric functional explorations

Prof. Vlad RATZIU

Gastroenterology and hepatology

Prof. Alban REDHEUIL

Cardiovascular imaging

The council of the IHU

The IHU board is made up of the general director of the IHU, the general secretary, the dean of the Sorbonne University faculty of medicine, the directors and team leaders of the UMRs involved in the ICAN, the medical director of the DMU Archimede, department heads of this DMU involved in the clinical activities of ICAN. The Chairman of the IHU Council is the Chief Executive Officer of the IHU. Its objective is to strengthen the internal cohesion of the medical and scientific community of the IHU and to allow a fluidity of information between the teams to ensure overall consistency. The purpose of the IHU council is to allow discussion and sharing on the strategic orientations and scientific policy of the IHU.

Prof. Zahir AMOURA

Head of the internal medicine department of the Pitié-Salpêtrière hospital


Head of the Molecular and Cellular Plasticity in Cardiovascular Diseases team – UMR 1166


Head of the Department of Endocrinology, Metabolism and Prevention of Cardiovascular Diseases

Prof. Philippe CHARRON

Head of the Genomics and Pathophysiology of Myocardial Diseases Research Team UMR 1166 and Director of the Reference Center for Cardiomyopathies and Hereditary Heart Rhythm Disorders

Prof. Laurent CHICHÉ

Head of the Cardiovascular Surgery Department at Saint Antoine Hospital


Head of the Endocrinology, Diabetology and Reproductive Medicine Department at Saint-Antoine Hospital

Prof. Karine CLEMENT

Head of UMR 1269 Nutriomics - Nutrition and obesity

Prof. Ariel COHEN

Head of the Cardiology Department at Saint Antoine Hospital

Prof. Jean-Philippe COLLET

Head of Interventional Cardiology Unit of the GH PSL Cardiology Institute, Head of Team 2 Atherothrombosis and Applied Pharmacology - UMR 1166

Prof. Alain Combès

Head of the resuscitation department at the Pitié-Salpêtrière hospital

Prof. Bruno FEVE

Director of research unit 938 – Saint-Antoine research center


Head of the metabolic diseases, diabetes and comorbidities team – UMR 1138 Cordeliers research center

Prof. Christian FUNCK-BRENTANO

Head of the Paris-Est Clinical Investigation Center (CIC)


Head of the diabetology department at IE3M

Prof. Chantal HOUSSET

Head of the team Fibroinflammatory diseases of metabolic and biliary origin of the liver - Research unit 938 – Saint-Antoine research center

Prof. Richard ISNARD



Cardiovascular imaging team leader UMR 1146

Wilfried LE GOFF

Team leader Cellular lipid metabolism in cardiovascular diseases – UMR 1166

Prof. Laurence LEENHARDT

Head of the Functional Unit for Thyroid and Endocrine Tumor Pathologies

Prof. Pascal LEPRINCE

Head of the Department of Cardiac Surgery at the Heart Institute of the Pitié-Salpêtrière Hospital Group

Philippe LESNIK

Head of the Mononuclear phagocytes in metabolic diseases team – UMR116


Head of the Cardiology Department of the Heart Institute of the Pitié Salpêtrière Hospital Group


Head of the Molecular and Cellular Plasticity in Cardiovascular Diseases team – UMR 1166

Prof. Irene NETCHINE

Head of the IGF system, fetal and postnatal growth team - Research unit 938 - Saint-Antoine research center

Prof. Michael OPPERT

Head of the nutrition department of the E3M institute and the human nutrition research center (CRNH)

Prof. Christine POITOU-BERNERT

Nutrition - Genetic Rare Obesity Reference Center

Prof. Alban REDHEUIL

Head of Cardiovascular Imaging Unit of the Heart Institute of the Pitié-Salpêtrière Hospital Group

Prof. Bruno RIOU

Dean of the Faculty of Medicine

Prof. Philippe TOURAINE

Head of Endocrinology and Reproductive Medicine

Prof. Corinne VIGOUROUX

Reference center for rare pathologies of insulin-secretion and insulin-sensitivity (PRISIS)

The scientific council

The scientific council of ICAN is composed of 5 external personalities, highly recognized by the international scientific community, in the field of cardiometabolism and nutrition. This scientific governance body, appointed by the Board of Directors, is consulted on the main scientific orientations and the annual action program of the IHU. The scientific council also evaluates the scientific performance of the Foundation. He is very involved in the scientific life of ICAN and plays a fundamental role in it.

Prof. Rozemarijn VLIEGENTHART

Radiologist and Professor of Cardiothoracic Imaging

Groningen University Medical Center


Prof. Michael RODEN

Professor of Endocrinology and Metabolic Diseases

Düsseldorf University Hospital


Prof. Karin SIPIDO

Professor of Medicine and Head of Experimental Cardiology

University of Leuven



Director of the “Diabetes, obesity and cardiovascular complications” research axis

Faculty of Medicine and Health Sciences of the University of Sherbrooke



Clinical Biochemistry, Laboratory Medicine and Pathology

University Center for Laboratory Medicine and Pathology (UZL)


Professor Rozemarijn Vliegenthart

Groningen University Medical Center - Netherlands

“ICAN is a unique research institute due to its multidisciplinary approach to a central and complex morbidity problem, cardiometabolic diseases, and broad research scope, from basic research to implementation, using state-of-the-art techniques.

A particular strength of this world-wide leading institute is the involvement of experts from different fields, including clinic, -omics and imaging, in research projects, leading to new insights on pathophysiology, biomarkers and potential targets for treatment or response evaluation.

Importantly, ICAN has a central focus on the patient, patient journey, and prevention. Lastly, I think a key component that helps to anchor the research findings and techniques is the ICAN education and teaching program for future colleagues in research and clinic. »